Amyloidosis, Inflammation, and Oxidative Stress in the Heart of an Alkaptonuric Patient
暂无分享,去创建一个
Eugenio Paccagnini | Pietro Lupetti | Annalisa Santucci | Giulia Bernardini | Cecilia Viti | Lia Millucci | Daniela Braconi | Federico Perfetto | E. Paccagnini | P. Lupetti | G. Giorgetti | D. Braconi | L. Millucci | Lorenzo Ghezzi | A. Santucci | F. Perfetto | C. Viti | Marcella Laschi | Adriano Spreafico | G. Bernardini | Marcella Laschi | M. Geminiani | Lorenzo Ghezzi | Maurizio Orlandini | Giovanna Giorgetti | Michela Geminiani | Patrizia Soldani | Chiara Benvenuti | C. Benvenuti | A. Spreafico | M. Orlandini | P. Soldani
[1] 髙梨 哲生. Synovial deposition of wild-type transthyretin-derived amyloid in knee joint osteoarthritis patients(変形性膝関節症患者の関節滑膜には野生型トランスサイレチン由来のアミロイドが沈着する) , 2013 .
[2] J. Butany,et al. Ochronosis and Aortic Valve Stenosis , 2006, Journal of cardiac surgery.
[3] W. Marsden. I and J , 2012 .
[4] H. Bayır,et al. Oxidized phospholipids as biomarkers of tissue and cell damage with a focus on cardiolipin. , 2012, Biochimica et biophysica acta.
[5] M. Bély,et al. Histochemical and immunohistochemical differential diagnosis of amyloidosis - a brief illustrated essay and personal experience with Romhányi's method , 2000, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[6] J. Jarvis,et al. Development of an in vitro model to investigate joint ochronosis in alkaptonuria. , 2011, Rheumatology.
[7] G. Valacchi,et al. Isoprostanes and 4-Hydroxy-2-nonenal: Markers or Mediators of Disease? Focus on Rett Syndrome as a Model of Autism Spectrum Disorder , 2013, Oxidative medicine and cellular longevity.
[8] Gérard Lizard,et al. Cytotoxic oxysterols induce caspase-independent myelin figure formation and caspase-dependent polar lipid accumulation , 2007, Histochemistry and Cell Biology.
[9] D. Braconi,et al. Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria , 2013, Rheumatology.
[10] J. Jarvis,et al. Recent advances in management of alkaptonuria (invited review; best practice article) , 2013, Journal of Clinical Pathology.
[11] M. Ono,et al. Aortic valve replacement for aortic stenosis caused by alkaptonuria. , 2013, The Annals of thoracic surgery.
[12] Annalisa Santucci,et al. Redox-proteomics of the effects of homogentisic acid in an in vitro human serum model of alkaptonuric ochronosis , 2011, Journal of Inherited Metabolic Disease.
[13] E. Selvi,et al. Evaluation of antioxiodant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model , 2010, Journal of cellular physiology.
[14] Annalisa Santucci,et al. Biochemical and Proteomic Characterization of Alkaptonuric Chondrocytes , 2011, Journal of cellular physiology.
[15] M. Bély,et al. Sensitivity and specificity of Congo red staining according to Romhányi. Comparison with Puchtler's or Bennhold's methods. , 2006, Acta histochemica.
[16] F. Parhami,et al. High-Density Lipoprotein Regulates Calcification of Vascular Cells , 2002, Circulation research.
[17] M. Rosenqvist,et al. Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. , 1994, Journal of the American College of Cardiology.
[18] Julian A. Smith,et al. Alkaptonuria‐Associated Aortic Stenosis , 2013, Journal of cardiac surgery.
[19] Eugenio Paccagnini,et al. Alkaptonuria is a novel human secondary amyloidogenic disease , 2012, Biochimica et biophysica acta.
[20] D. Braconi,et al. Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis. , 2010, Rheumatology.
[21] G. Valacchi,et al. Free radicals and antioxidants: how to reestablish redox homeostasis in chronic diseases? , 2013, Current medicinal chemistry.
[22] S. Ikeda,et al. Synovial deposition of wild-type transthyretin-derived amyloid in knee joint osteoarthritis patients , 2013, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[23] R. Stephenson. A and V , 1962, The British journal of ophthalmology.
[24] Rosario V. Freeman,et al. Spectrum of Calcific Aortic Valve Disease: Pathogenesis, Disease Progression, and Treatment Strategies , 2005, Circulation.
[25] R. Detrano,et al. Predicting coronary events with coronary calcium: pathophysiologic and clinical problems. , 2000, Current problems in cardiology.
[26] N. Chen,et al. Pathophysiology of Vascular Calcification in Chronic Kidney Disease , 2004, Circulation research.
[27] D. Braconi,et al. Post‐genomics of bone metabolic dysfunctions and neoplasias , 2012, Proteomics.
[28] C. Cervellati,et al. Hypoxia induces cell damage via oxidative stress in retinal epithelial cells , 2014, Free radical research.
[29] I. Goldberg,et al. Sphingolipids and cardiovascular diseases: lipoprotein metabolism, atherosclerosis and cardiomyopathy. , 2011, Advances in experimental medicine and biology.
[30] E. Selvi,et al. Homogentisate 1,2 Dioxygenase is Expressed in Human Osteoarticular Cells: Implications in Alkaptonuria , 2011, Journal of cellular physiology.
[31] N. Rajamannan. Oxidative‐mechanical stress signals stem cell niche mediated Lrp5 osteogenesis in eNOS−/− null mice , 2012, Journal of cellular biochemistry.
[32] Y. Bossé,et al. Amyloid substance within stenotic aortic valves promotes mineralization , 2012, Histopathology.
[33] Annalisa Santucci,et al. Proteomic and redox‐proteomic evaluation of homogentisic acid and ascorbic acid effects on human articular chondrocytes , 2010, Journal of cellular biochemistry.